Skip to content
PubMed This is a summary of 62 peer-reviewed journal articles Updated
Neurology

Brain Small Vessel Disease 4 (BSVD4): A Patient Guide

At a Glance

BSVD4 is a rare COL4A1-related condition caused by an AluYa5 insertion that can weaken small brain vessels. Care centers on individualized blood pressure control, careful medication decisions, avoiding head trauma, and monitoring neurological, eye, and kidney health.

This guide provides educational information about COL4A1-related cerebral small-vessel disease (specifically the AluYa5 subtype, often referred to as BSVD4) and does not replace individualized medical advice from your care team.

Brain Small Vessel Disease 4 (BSVD4) is a rare genetic condition that alters how the body builds and maintains its smallest blood vessels. It is caused by a specific genetic variation known as an AluYa5 insertion in the COL4A1 gene, which acts as a set of instructions for building collagen type IV. This collagen serves as the “scaffolding” or basement membrane that supports and strengthens vessel walls. In people with BSVD4, this genetic glitch is thought to alter the regulation of collagen production, which can weaken the vessel walls and make them more susceptible to injury [1].

Because this supportive scaffolding is found throughout the body, BSVD4 is considered a multisystem condition. While it most significantly affects the small vessels of the brain—leading to areas of small-vessel injury known as ischemic strokes, tiny leaks called microbleeds, or more significant hemorrhages—it can also involve the eyes and kidneys. This broader spectrum of symptoms is sometimes referred to as Gould Syndrome. Understanding that this is a systemic condition allows you and your medical team to look beyond neurological symptoms and proactively monitor the health of your vision and kidney function over time [2].

Living with BSVD4 requires a specialized approach to protective care. The most critical factor in this management is individualized blood pressure control, which generally helps reduce the physical “pressure” exerted on vulnerable vessel walls. Additionally, because the condition involves a unique risk of both bleeding and blockages, decisions regarding medications like aspirin or blood thinners must be highly individualized and should never be stopped or started without consulting your prescriber. Doctors also typically recommend avoiding activities that carry a high risk of head trauma, as even minor injuries can have more significant consequences for those with this genetic profile [3][4].

A diagnosis of BSVD4 provides a roadmap for long-term health rather than a definitive prediction of the future. The condition is known for its variable expressivity, meaning that the way it affects one person can be very different from how it affects another, even within the same family. By working with a multidisciplinary team—including neurologists, geneticists, and other specialists—you can establish a baseline of your health through specialized imaging and routine screenings. This proactive monitoring empowers you to manage the condition effectively, focusing on the modifiable risks and lifestyle adjustments that keep your vascular system as healthy as possible [5].

Common questions in this guide

What is BSVD4 and what causes it?
BSVD4 is a rare genetic condition caused by an AluYa5 insertion in the COL4A1 gene. This gene helps the body make collagen that supports blood-vessel walls, so the change can make small vessels—especially in the brain—more vulnerable to injury. The condition can also affect the eyes and kidneys.
What brain and body problems can BSVD4 cause?
BSVD4 can lead to ischemic strokes, tiny brain bleeds called microbleeds, or larger brain hemorrhages. Because COL4A1-related vessel support is found throughout the body, eye and kidney problems may also occur. The severity and combination of findings can differ widely, even among relatives.
How is BSVD4 managed and monitored over time?
Care commonly includes an individualized blood pressure plan, brain imaging, and routine attention to vision and kidney function. A neurologist, geneticist, and other specialists can coordinate monitoring based on a person’s findings. Avoiding activities with a high risk of head trauma may also be advised.
Is it safe to take aspirin or a blood thinner with BSVD4?
The decision must be individualized because BSVD4 can involve both blocked vessels and bleeding. Your prescriber should weigh your imaging and overall health before recommending or changing aspirin or a blood thinner. Do not start or stop these medicines on your own.
What specialists should care for someone with BSVD4?
A neurologist and a medical geneticist are central to evaluating and monitoring BSVD4. Additional specialists may be involved when the eyes or kidneys are affected, and the team can set imaging, screening, blood pressure, and medication plans.
Does a BSVD4 diagnosis predict how severe the condition will be?
No. BSVD4 has variable expressivity, meaning people with the same condition—even members of one family—may have different symptoms and levels of vascular involvement. A diagnosis helps guide personalized monitoring and risk reduction, but it cannot determine an individual’s exact future.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on brain small vessel disease 4.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you confirm my specific genetic mutation is the AluYa5 insertion in the COL4A1 gene?
  2. 2.What are your specific blood pressure targets for me based on my overall health?
  3. 3.Which specialists should be part of my core care team?
  4. 4.Given my imaging results, how should we weigh the risks and benefits of antiplatelet or blood-thinning medications?
  5. 5.What forms of aerobic and resistance exercise are safe and beneficial for me?

References

References (5)
  1. 1

    An AluYa5 Insertion in the 3'UTR of COL4A1 and Cerebral Small Vessel Disease.

    Aloui C, Neumann L, Bergametti F, et al.

    JAMA network open 2024; (7(4)):e247034 doi:10.1001/jamanetworkopen.2024.7034.

    PMID: 38630472
  2. 2

    Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol.

    Gasparini S, Balestrini S, Saccaro LF, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2024; (196(4)):e32099 doi:10.1002/ajmg.c.32099.

    PMID: 39016117
  3. 3

    Late-onset intracerebral hemorrhage associated with COL4A1 variants: clinical and genetic perspectives.

    Zhuang X, Xu S, Chen C, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(1)):97.

    PMID: 41484600
  4. 4

    Updates on Prevention of Hemorrhagic and Lacunar Strokes.

    Tsai HH, Kim JS, Jouvent E, Gurol ME

    Journal of stroke 2018; (20(2)):167-179 doi:10.5853/jos.2018.00787.

    PMID: 29886717
  5. 5

    Main features of COL4A1-COL4A2 related cerebral microangiopathies.

    Guey S, Hervé D

    Cerebral circulation - cognition and behavior 2022; (3()):100140 doi:10.1016/j.cccb.2022.100140.

    PMID: 36324412

This BSVD4 information is for education and does not replace medical advice. Discuss genetic testing, blood pressure targets, medications, exercise, and monitoring with your neurologist and genetic specialist.